Cite
HARVARD Citation
Malagola, M. et al. (2023). Busulfan or Treosulfan Conditioning Platform for Allogeneic Stem Cell Transplantation in Patients Aged >60 Y With Acute Myeloid Leukemia/Myelodysplastic Syndrome: A Subanalysis of the GITMO AlloEld Study. Transplantation direct. 9 (3), pp. e1451-. [Online].